Combined inhibition of insulin-like growth factor-1 receptor enhances the effects of gefitinib in a human non-small cell lung cancer resistant cell line

By Qi Hui wei   Shen Zan   Fan Li hong  

Experimental and Therapeutic Medicine, Vol. 2, Iss. 6, 2011-11 ,pp. : 1091-1095

Spandidos Publications

Access to resources Recommend Favorite

Transforming Growth Factor- Negatively Modulates Proliferation and c-fosExpression of the Human Endometrial Adenocarcinoma Cell Line HEC-1-A

By Bergman C.A.   Talavera F.   Christman G.M.   Baker V.V.   Roberts J.A.   Menon K.M.J.  

Gynecologic Oncology, Vol. 65, Iss. 1, 1997-04 ,pp. : 63-68

Elsevier

Access to resources Recommend Favorite

Elevated Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-2 in Malignant Pleural Effusion

By Olchovsky David   Shimon Ilan   Goldberg Iris   Shulimzon Tiberiu   Lubetsky Aharon   Yellin Alon   Pariente Clara   Karasik Avraham   Kanety Hannah  

Acta Oncologica, Vol. 41, Iss. 2, 2002-04 ,pp. : 182-187

Informa Healthcare

Access to resources Recommend Favorite

Insulin-like growth factor binding proteins 1 and 3 and breast cancer outcomes

By Goodwin P.J.  

Breast Cancer Research and Treatment, Vol. 74, Iss. 1, 2002-07 ,pp. : 65-76

Springer Publishing Company

Access to resources Recommend Favorite

Epidermal Growth Factor Activates Protein Kinase C in the Human Endometrial Cancer Cell Line HEC-1-A

By Connor P.   Talavera F.   Kang J.-S.   Burke J.   Roberts J.   Menon K.M.J.  

Gynecologic Oncology, Vol. 67, Iss. 1, 1997-10 ,pp. : 46-50

Elsevier

Access to resources Recommend Favorite